Description: |
Amprenavir is an human immunodeficiency virus (HIV) protease inhibitor with IC50 of 14.6 ± 12.5 ng/ml For wild-type HIV isolates. Like all HIV protease inhibitors, amprenavir interrupts the maturation phase of the HIV replicative cycle by Forming an inhibitor-enzyme complex, which prevents HIV protease from binding with its normal substrates. It has an enzyme inhibition constant (Ki = 0.6 nM) that falls within the Ki range of the other protease inhibitors. For the detailed information of Amprenavir, the solubility of Amprenavir in water, the solubility of Amprenavir in DMSO, the solubility of Amprenavir in PBS buffer, the animal experiment (test) of Amprenavir, the cell expriment (test) of Amprenavir, the in vivo, in vitro and clinical trial test of Amprenavir, the EC50, IC50,and Affinity of Amprenavir, Please contact DC Chemicals. |